Progesterone and estrogen receptor expression by canine cutaneous soft tissue sarcomas
Carregando...
Data
2020-01-01
Autores
Loures, Fabricia H.
Conceição, Lissandro G.
Amorim, Renee L. [UNESP]
Nobrega, Juliano [UNESP]
Neto, Rafael T.
Costa, Eduardo P.
Fonseca e Silva, Fabyano
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Canine soft tissue sarcomas (STS) comprise a heterogeneous group of malignancies that share similar histopathological features, a low to moderate recurrence rate and low metastatic potential. In human medicine, the expression of estrogen receptors (ER) and progesterone receptors (PR) in sarcomas has been studied to search for prognostic factors and new treatment targets. Similar studies have yet to be conducted in veterinary medicine. The objective of this study was therefore to investigate by immunohistochemistry (IHC) the ER and PR expression in a series of 80 cutaneous and subcutaneous sarcomas in dogs with histopathological features of peripheral nerve sheath tumor (PNST) and perivascular wall tumor (PWT). All cases were positive for PR and negative for ER. Tumors of high malignancy grade (grade III) exhibited higher PR expression than low-grade tumors (grade I). Tumors with mitotic activity greater than 9 mitotic figures/10 high power fields also exhibited higher PR expression. In addition, there was a positive correlation between cell proliferation (Ki67) and PR expression. Therefore, it is possible that progesterone plays a greater role than estrogen in the pathogenesis of these tumors. Future studies should explore the potential for selective progesterone receptor modulators as therapeutic agents in canine STS, as well as evaluating PR expression as a predictor of prognosis.
Descrição
Palavras-chave
Canine, Cutaneous tissue, Dogs, Estrogen, Progesterone, Receptor expression, Soft tissue sarcomas
Como citar
Pesquisa Veterinaria Brasileira, v. 40, n. 4, p. 284-288, 2020.